Epithelioid Hemangioendothelioma: Symptoms, Causes, Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr Kovvuru Bhaskar Reddy , Oncologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Epithelioid Hemangioendothelioma (EHE) is a rare vascular tumor that arises from the endothelial cells lining blood vessels. It is considered a malignant tumor with intermediate aggressiveness, meaning its behavior falls between a benign hemangioma and an aggressive angiosarcoma. EHE can develop in various organs, including the liver, lungs, bones, and soft tissues, and symptoms vary depending on the affected site.

Some individuals remain asymptomatic, while others experience pain, swelling, cough, shortness of breath, or organ-specific symptoms. Early diagnosis and specialized treatment are essential to determine the extent of the disease, guide therapy, and improve long-term outcomes.

What are the Symptoms of Epithelioid Hemangioendothelioma?

Symptoms of EHE largely depend on the tumor's location and size. Common symptoms include:

Pain: Often the first symptom, especially if the tumor is located in the bone or soft tissue.
Swelling or Palpable Mass: Particularly in the extremities or superficial locations.
Respiratory Symptoms: Such as cough or dyspnea, when the lungs are involved.
Jaundice or Abdominal Discomfort: Indicative of liver involvement.

These symptoms are non-specific, often leading to delays in diagnosis.

What are the Causes of Epithelioid Hemangioendothelioma?

The precise causes of EHE are not well understood. Molecular studies have identified specific genetic translocations, notably the WWTR1-CAMTA1 fusion, which play a crucial role in pathogenesis. These genetic aberrations disrupt normal cellular pathways, leading to tumorigenesis. However, the triggers for these genetic changes remain elusive.

In some cases, alternative gene fusions such as YAP1-TFE3 have also been identified, suggesting that different molecular pathways may contribute to the development of this rare tumor. Environmental or lifestyle risk factors have not been clearly established, and most cases appear to occur sporadically without a strong hereditary pattern. Ongoing research aims to better understand these genetic mechanisms, which may help guide targeted therapies and improve treatment outcomes in the future.

When to See a Doctor for Epithelioid Hemangioendothelioma?

Anyone experiencing persistent unexplained pain, swelling, breathing difficulties, abdominal discomfort, or a growing soft tissue mass should consult a Medical Oncologist or Surgical Oncologist for evaluation.

You should see a doctor if you experience:

A persistent lump or swelling
Unexplained bone or abdominal pain
Persistent cough or shortness of breath

Seek immediate medical attention if you:

Develop severe breathing difficulty
Experience sudden severe abdominal pain or signs of liver failure
Have a pathological fracture or sudden neurological symptoms due to tumor spread

These symptoms may indicate advanced disease or serious complications requiring urgent medical treatment.

Find Oncologists for Epithelioid Hemangioendothelioma Treatment Near You

How Is Epithelioid Hemangioendothelioma Diagnosed?

EHE diagnosis involves a combination of imaging, histological examination, and genetic testing. Imaging studies such as MRI and CT scans help delineate the extent of the disease. A definitive diagnosis is made through biopsy and histopathological analysis, supported by immunohistochemistry and genetic testing to identify characteristic translocations.

Imaging Techniques

Imaging plays a critical role in both diagnosis and monitoring of EHE. MRI provides detailed soft tissue contrast, essential for assessing the tumour's involvement and its relation to adjacent structures. CT scans are particularly useful for evaluating pulmonary and hepatic lesions.

Histopathological and Genetic Analysis

Histopathological analysis is essential for confirming the diagnosis, with immunohistochemistry providing additional specificity. Genetic testing for WWTR1-CAMTA1 and YAP1-TFE3 fusions can be performed using techniques such as fluorescence in situ hybridization (FISH) or reverse transcription-polymerase chain reaction (RT-PCR).

What are the Treatment Options for Epithelioid Hemangioendothelioma?

Treatment strategies for EHE are tailored based on tumor location, size, and metastatic status. Options include:

Surgical Resection: Considered the primary treatment for localized tumors, aiming for complete excision with clear margins.
Radiation Therapy: Used as an adjunct to surgery or as a palliative measure in inoperable cases.
Chemotherapy: Limited effectiveness, generally reserved for metastatic disease or in cases where surgery and radiation are not viable.
Targeted Therapy: Emerging treatments targeting specific genetic mutations offer promising avenues, though they remain largely experimental.

Prognosis for Patients with Epithelioid Hemangioendothelioma

Prognosis in EHE varies significantly based on several factors, including tumour size, location, and extent of metastasis. Patients with the localized disease generally have a favourable prognosis following complete surgical resection.

However, metastatic disease is associated with a poorer outcome, underscoring the importance of early detection and intervention. Long-term follow-up is crucial due to the potential for late recurrences.

Your health is everything - prioritize your well-being today.

Consult Epithelioid Hemangioendothelioma Doctors Today